05.06.2026

Pharmaceutical company Biofarm (BIO.RO) is to become subject to a voluntary tender offer (VTO) from Zakłady Farmaceutyczne Polpharma S.A, a Polish pharmaceutical producer. The announcement came from more

05.05.2026

Drug and supplement producer Biofarm ended the first quarter of 2026 with RON32.5 million net profit, up 0.6% from Q1/2025, despite smaller sales revenues and rising operational expenses. more

03.24.2026

The Board of Directors of drug manufacturer Biofarm (stock symbol: BIO) has convened the general meeting of shareholders on April 28 to vote on distributing dividends in the amount of RON41.4 million, more

02.12.2026

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has sold a building on Iancu de Hunedoara Boulevard in downtown Bucharest to Iancu de Hunedoara Residence, for EUR5 million. more

01.13.2026

Drug manufacturer Biofarm Bucuresti wants to identify strategic opportunities supporting the company’s development plans, considering organic investments among others, but also identifying some more

11.14.2025

Drug manufacturer Biofarm (stock symbol: BIO) ended the first nine months of 2025 with a turnover of RON263.2 million, up 14% against the year-earlier period, and EBITDA climbed 16% to RON109 million. more

10.21.2025

Biofarm Bucuresti, one of the ten largest local drug manufacturers, has earmarked investments in its own drug brands, but also in new products it is set to launch on the market. more

08.18.2025

Drug manufacturer Biofarm (BIO.RO) posted sales revenue of RON162.9 million in the first half of 2025, up 15% from the same period in 2024, while net profit increased by 16% to RON48.8 million, more

06.23.2025

Biofarm, one of the leading pharmaceutical producers in Romania, which has two plants in Bucharest, plans to invest in retooling its first facility and develop a new research and development center, more

05.15.2025

Pharma producer Biofarm in the first quarter of 2025 registered sales revenues of RON95 million, up 33%, and RON32 million net profit, 57% above the Q1/2024 level. more

04.29.2025

Shareholders of pharmaceutical producer Biofarm (BIO.RO) approved at their general meeting on April 28 the distribution of the company's net profit of RON74.4 million for 2024, as per a report sent to more

03.20.2025

Pharmaceutical producer Biofarm (BIO.RO), has called shareholders for extraordinary and ordinary general meetings on April 29 to vote among others for the distribution of the RON74.4 million net more

11.14.2024

Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first nine months of 2024 with net profit of RON73.25 million, at an individual level, up 4.7% from the same period of 2023, as more

08.22.2024

Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first half of 2024 with net profit of RON42 million, down 17% from RON50.2 million reported in the same period of 2023, as per more

05.14.2024

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) ended the first three months of 2024 with net profit of RON20.6 million, down almost 35% from the same period of 2023, as per its quarterly financial more

04.24.2024

In their ordinary general meeting of April 24, the shareholders of pharmaceutical producer Biofarm Bucuresti (BIO.RO) approved, among others, the financial statements for 2023, the budget of revenue more

03.20.2024

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has called shareholders to approve, among others, the distribution of RON30.5 million dividends from 2023 net profit. more

12.18.2023

Biofarm, a top five drug manufacturer locally, plans to expand on other foreign markets, both in and outside Europe. more

11.14.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) announced in its financial report released on Nov 14 that its sales income grew by 9.7% on the year to RON229 million in the first nine months of more

10.05.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has informed the local capital market in a report about the decisions taken at the Extraordinary General Meeting of Shareholders of October 5, among more

09.12.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has sold a plot of land to the company Iancu de Hunedoara Residence SRL for approximately EUR5 million. more

08.12.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) reported a profit of RON50.1 million for January-June 2023, up 15% from RON43.6 million reported for the same period of 2022. more

05.11.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) estimates a turnover of approximately RON325 million for 2023, up 17% versus 2022 level, and a 6% higher net profit compared to 2022 when it reported more

04.10.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO), the fifth largest drug producer in Romania, has budgeted revenue of RON325 million for 2023, which translates into a 17% increase compared to the more

03.21.2023

Pharmaceutical producer Biofarm (BIO.RO) has called shareholders for April 26, 2023 to approve distribution of the 2022 net profit and of the RON0.03 per share gross dividend, reports to the more